Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection - Test2 - elhamkhani - TriplyDB

Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection

Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection

http://www.wikidata.org/entity/Q34261822

about

Genetics and visceral leishmaniasis: of mice and man Leishmaniasis, an emerging disease found in companion animals in the United States Determinants for the development of visceral leishmaniasis disease Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis Genetic admixture in Brazilians exposed to infection with Leishmania chagasi.Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan.Visceral Leishmaniasis Eradication is a Reality: Data from a Community-based Active Surveillance in Bangladesh.TNF-α promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis.IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production.Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-alpha.Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.Genetic control of canine leishmaniasis: genome-wide association study and genomic selection analysis.A protocol to identify non-classical risk factors for preterm births: the Brazilian Ribeirão Preto and São Luís prenatal cohort (BRISA).Identification of risk areas for visceral leishmaniasis in Teresina, Piaui State, Brazil Is there a future for TNF promoter polymorphisms?Genetic polymorphisms associated with the inflammatory response in bacterial meningitis.Risk factors for kala-azar in Bangladesh.The immunopathology of experimental visceral leishmaniasis.New means of canine leishmaniasis transmission in north america: the possibility of transmission to humans still unknown.Recent developments leading toward a paradigm switch in the diagnostic and therapeutic approach to human leishmaniasis Cutaneous leishmaniasis: disease susceptibility and pharmacogenetic implications.HLA and infectious diseases.Vaccine Development Against Leishmania donovani.Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis.Host genetic factors in American cutaneous leishmaniasis: a critical appraisal of studies conducted in an endemic area of Brazil.Immune responses during cutaneous and visceral leishmaniasis.Lipoprotein lipase and PPAR alpha gene polymorphisms, increased very-low-density lipoprotein levels, and decreased high-density lipoprotein levels as risk markers for the development of visceral leishmaniasis by Leishmania infantum.In Egyptians, a mutation in the lymphotoxin-alpha gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection.Canine leishmaniasis in North America: emerging or newly recognized?Serum Cytokine Responses over the Entire Clinical-Immunological Spectrum of Human Leishmania (L.) infantum chagasi Infection.Biochemical and nutritional evaluation of patients with visceral leishmaniasis before and after treatment with leishmanicidal drugs.Leishmania infantum: illness, transmission profile and risk factors for asymptomatic infection in an endemic metropolis in Brazil.Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients.Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil.The role of IL15 gene variants in visceral leishmaniasis among Iranian patients.Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis.Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation.

P2860

Q24612701-07DF96A5-74F3-4751-85B5-0759E796E851 Q24647678-F5FA4CCE-21AF-4C30-8A89-638E00EE309C Q27027871-1B2EBD31-AFEA-4108-8C96-9E96B7C1819B Q28483511-B5D8C696-3FAD-486F-8217-B2ABB5183F91 Q30438885-1935EF3E-7267-47B8-935F-02920C4B39AB Q30441556-E93C4C35-17B7-4645-95F3-689BA9A7B9A5 Q30442586-FB556CF5-BCD5-48BA-B0BF-5283625852FE Q30607636-213A3287-A3B6-4D91-A354-95D4FDB082B2 Q31046470-FCD93292-C312-4799-8F1C-BD896CE576F3 Q33282667-E239EAA8-B14F-4F70-94F9-DCB8C7AA3EB4 Q33452545-A35896AD-05FE-42B1-9BCF-25E466ECEDE3 Q33531749-87C7AA5E-CA07-480A-AAF1-0D3A3DEC9F3B Q34256392-E75E180B-911D-4A6A-A3D4-3936A60DFDB6 Q34581586-DDB4FB7F-6E39-4479-8457-91D9A60328E7 Q34875474-986544DF-EC0D-4A40-A528-66CDB461130B Q35671253-D214F532-6E3F-4D2D-AF57-087C8D9B6646 Q35758305-FFED5069-9529-4CB9-843D-4BA0854E5BD3 Q35873114-8F9A0AD6-299F-427A-A2D9-007763E5913C Q35884243-64E32967-B29B-4F85-A485-3C3E145C8AEF Q37226400-1CF33266-56D1-425F-B12F-7DF5BAA58D50 Q37251607-D99F1C56-AABB-40AD-AB74-FD83BC3F17AC Q37416125-A173D896-B4FE-4A55-ADC2-49D67924F2F9 Q37444410-37C8D687-4E4B-463E-9EE1-619D3A129865 Q38012112-615448F9-71A0-4BA0-86DA-24F3F6D952F2 Q38096324-E522C788-4D44-4450-B5AE-B5281359F011 Q38215168-271BAB4B-CD27-463A-90B3-06DF9A8852FA Q38235268-20362CF4-2311-4A52-8036-C6FFD9A4FFA1 Q38933584-09809654-AC08-46ED-A337-DEF5206A5979 Q38992504-B6B20EB0-C590-4B9E-BA17-0C5E3E546530 Q39351775-C0529836-78AD-4A9E-A94F-DC0FA067689D Q39381958-9D665032-E8C7-495F-9457-686A6B58C495 Q40219731-16E8A670-A2A0-4AC9-9694-D4BF8FB2C05C Q40432786-64BB3607-FD34-4159-8C76-38C183818AC4 Q40627316-4E49E8C5-5D96-4284-8D8F-4DA814BD58BD Q41259097-AC63B3DC-1EC8-40B7-B639-9E7B93F472DA Q45045228-E3C4BEA9-CA56-4DC1-B4EB-FFDAB1C22D0C Q45326725-01DA9937-6528-4FBA-8628-3695CBD20C18 Q47759419-CA2FE982-E0A7-400B-84F8-D75026633743

P2860

Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection

http://www.wikidata.org/entity/Q34261822

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Association between the tumor ...... f Leishmania chagasi infection

@ast

Association between the tumor ...... f Leishmania chagasi infection

@en

Association between the tumor ...... f Leishmania chagasi infection

@nl

type

label

Association between the tumor ...... f Leishmania chagasi infection

@ast

Association between the tumor ...... f Leishmania chagasi infection

@en

Association between the tumor ...... f Leishmania chagasi infection

@nl

prefLabel

Association between the tumor ...... f Leishmania chagasi infection

@ast

Association between the tumor ...... f Leishmania chagasi infection

@en

Association between the tumor ...... f Leishmania chagasi infection

@nl

P1433

Q34261822-04CC22A6-4D7C-45BD-B5C2-4CAE37E3CA07

P1476

Q34261822-DA644D97-71F3-4045-B7B2-4B0F4C902112

P2093

Q34261822-055C64FB-9146-4732-87B5-F16149C50C61

Q34261822-1B9E8AE1-61ED-487A-8CC7-15960CE1C6FC

Q34261822-23F11B68-B081-4FFA-B8A8-FAAB30888B89

Q34261822-421FB7CB-7F16-4F41-8EE6-D6D236D67D9B

Q34261822-5206FF8E-88D6-4973-AC29-9A72FFF3C23E

Q34261822-5A451D87-9E54-47DA-8F4A-35E5C1B7A3BE

Q34261822-A03D5D47-6DB2-45A8-9C36-5F36A10233DE

Q34261822-D2F18BC1-B1F3-483B-A15B-CFC2EE075943

Q34261822-D41BADB5-D8BF-4A8D-B4E8-C00FF4396EAC

Q34261822-F1B37452-8041-4E03-83B3-E01056D7A74F

P2860

Q34261822-002109BE-3C3C-484F-B377-8E4E39B92247

Q34261822-0C408202-620B-4719-A084-51B815C91735

Q34261822-1205C5D1-B92C-4CA1-9335-C8847DD443EF

Q34261822-19833DE8-C9A7-4E6C-94A4-2FB2D3C9EA88

Q34261822-1A97336B-FCEA-4EEE-9E14-96B9ADD45DEA

Q34261822-24F3B356-B712-4849-BA9A-7D7B04EBC8C4

Q34261822-27536DF0-805F-414E-B870-18A63F15AF55

Q34261822-28316A78-D6AE-4ED7-8A2C-D985293C27A1

Q34261822-28701112-58A3-497A-8D13-38A748C056D6

Q34261822-39C969CA-3A1B-4B5A-8A27-D0BF668431F7

P304

Q34261822-8C25D01F-9114-4F2D-8A89-CF5822F1D3A9

P31

Q34261822-EA243ECA-C124-4DF7-84FA-1958A0F34093

P356

Q34261822-C01892AD-8696-4588-924F-93F837A5853B

P407

Q34261822-0078483B-2EF5-46E0-8AE7-E7D1D2EA1B18

P433

Q34261822-7939108B-C64F-48BB-A5BE-E8FCF903E6A6

P478

Q34261822-D89C98BF-160D-4208-960B-FD2F4CE5141A

P577

Q34261822-88EC9730-A232-4F19-85EA-3E82B91EFB10

P698

Q34261822-D7D059DB-1C9E-46D9-9152-A7D431B877C5

P932

Q34261822-19AE3A93-84AB-47C7-8908-65CA1C7CD658

P356

IAI.70.12.6919-6925.2002

P1433

Infection and Immunity

P1476

Association between the tumor ...... f Leishmania chagasi infection

@en

P2093

Adele A Mitchell

http://www.w3.org/2001/XMLSchema#string

Bethany K Helms

http://www.w3.org/2001/XMLSchema#string

Elizabeth W Pugh

http://www.w3.org/2001/XMLSchema#string

Fabiana L Bezerra

http://www.w3.org/2001/XMLSchema#string

Haeok Chang

http://www.w3.org/2001/XMLSchema#string

Jeffrey C Murray

http://www.w3.org/2001/XMLSchema#string

Mary E Wilson

http://www.w3.org/2001/XMLSchema#string

Regina F S Braz

http://www.w3.org/2001/XMLSchema#string

Selma M B Jeronimo

http://www.w3.org/2001/XMLSchema#string

Theresa M Karplus

http://www.w3.org/2001/XMLSchema#string

P2860

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

Canine visceral leishmaniasis in northeast Brazil: assessment of serodiagnostic methods.

Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot.

Clinical spectrum of Leishmaniasis.

The role of tumor necrosis factor in health and disease.

Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal models

Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis

Immunomodulation by thalidomide and thalidomide analogues

Polymorphism of the human TNF-alpha promoter--random variation or functional diversity?

P304

6919-6925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.70.12.6919-6925.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12438370

http://www.w3.org/2001/XMLSchema#string

P932

133071

http://www.w3.org/2001/XMLSchema#string